Discontinued — last reported Q3 '25
CF Industries Equity Method Investments increased by 21.9% to $39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $33.00M to $39.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a -16.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.00M | $92.00M | $82.00M | $84.00M | $79.00M | $86.00M | $74.00M | $81.00M | $72.00M | $32.00M | $26.00M | $29.00M | $25.00M | $28.00M | $29.00M | $33.00M | $35.00M | $35.00M | $32.00M | $39.00M |
| QoQ Change | — | +12.2% | -10.9% | +2.4% | -6.0% | +8.9% | -14.0% | +9.5% | -11.1% | -55.6% | -18.8% | +11.5% | -13.8% | +12.0% | +3.6% | +13.8% | +6.1% | +0.0% | -8.6% | +21.9% |
| YoY Change | — | — | — | — | -3.7% | -6.5% | -9.8% | -3.6% | -8.9% | -62.8% | -64.9% | -64.2% | -65.3% | -12.5% | +11.5% | +13.8% | +40.0% | +25.0% | +10.3% | +18.2% |